SITC Certificate Program Logo.png

Earn a Certificate in Cancer Immunotherapy to support your knowledge and skills to provide effective and safe care for patients treated with cancer immunotherapy. The SITC-G Certificate Track includes comprehensive training on checkpoint inhibitors, cell therapies and many others, as well as the management of side effects, so you can successfully implement immunotherapy in clinical practice. 

Start the SITC-G Certificate

SITC-G Certificate TrackNon-certificate TrackCME InformationCertificate Task Force

Eight Learning Modules

The Certificate in Cancer Immunotherapy consists of eight independent learning modules that can be stacked to earn the SITC Graduate in Cancer Immunotherapy (SITC-G) certificate.

Approved for CME, CNE, CPE and MOC Credits

The SITC-G certificate identifies a healthcare provider as completing specialized training in cancer immunotherapy.  All modules are approved for CME, CNE, CPE and MOC credits, except where noted.

CP1.png

SITC-G Certificate Track

Requirements: Available only to those that fit the following parameters: Must be a treating physician (U.S. licensed MD / DO or global equivalent), or a practicing licensed NP, PA, PharmD or RPh degree holder involved in direct clinical services, or global equivalent.

To receive your SITC-G certificate, you must complete the 8 modules of course work below and successfully pass the final assessment. The final assessment consists of 80 multiple choice questions that test on all 8 modules of content. If you do not successfully complete the final assessment in those parameters, SITC will require you to go through the modules of content again - please email education@sitcancer.org to have the content reset for you.

SITC Member Pricing - $200.00

Low to Lower-Middle Income Economies: $0.00
(Not available to those in the industry work setting)

Non-Member Pricing - $250.00

Low to Lower-Middle Income Economies: $25.00
(Not available to those in the industry work setting)

Full Coursework Access

(includes all 8 modules and the final assessment)

Register Today

Assessment

To pass the final assessment, you must receive a grade of 80% or above. You will have 3 attempts and 65 minutes to complete the test in full.

Please Note

If you have previously completed the modules individually and are eligible to take the final assessment, please email us to receive the final assessment.

Module 1

Basic Immunology Concepts

Updated Version Available Now (As of 10/14/2022*) 

Module 2

Basic Cancer Immunotherapy Concepts

Updated Version Available Now (As of 11/14/2022*)

Module 3

Immune Checkpoint Blockade

Updated Version Available Now (As of 03/20/2023*)

Module 4

Managing Immune Checkpoint Inhibitor Adverse Events

Module 5

Other Approaches (Cytokines, Vaccines and Immune Cell Engagers)

Module 6

Oncolytic Viruses and Intralesional Therapy

Updated Version Available Now (As of 11/29/2022*)

Module 7

CAR T Cell and Cellular Therapy

Updated Version Available Now (As of 04/05/2023*)

Module 8

Implementing Cancer Immunotherapy in Clinical Practice

Non-Certificate Track

Requirements: For learners that do not qualify for the SITC-G certificate, SITC welcomes you to take each modules to further your immunology/immunotherapy education. Learners are able to earn CME, CNE, CPE and MOC credit (as available in each module). Each module is available individually.

SITC Member Pricing - $25.00 per module

Low to Lower-Middle Income Economies: $0.00
(Not available to those in the industry work setting)

Non-Member Pricing - $31.25 per module

Low to Lower-Middle Income Economies: $3.13* per module
(Not available to those in the industry work setting)

Module 1

Basic Immunology Concepts

Updated Version Available Now (As of 10/14/2022*) 

Basic Immunology Concepts will cover some of the key immunology needed to understand the rest of the certificate program.

Module 2

Basic Cancer Immunotherapy Concepts

Updated Version Available Now (As of 11/14/2022*)

Basic Cancer Immunotherapy Concepts, will cover the biological foundation of cancer immunotherapy, applying the basic immunology you learned in the last module to help lay the foundation for future topics in this program.

Module 3

Immune Checkpoint Blockade

Updated Version Available Now (As of 03/20/2023*)

Immune Checkpoint Blockade, will cover the biological foundation of immune checkpoint blockade therapies as well as diving into their clinical use.

Module 4

Managing Immune Checkpoint Inhibitor Adverse Events

Managing Immune Checkpoint Inhibitor Adverse Events, will cover the presentations, diagnosis and management of adverse events resulting from immune checkpoint inhibitor treatments.

Module 5

Other Approaches (Cytokines, Vaccines and Immune Cell Engagers)

Other approaches (Cytokines, vaccines, immune cell engagers), will cover the biological foundation and clinical implementation of cytokines, vaccines and immune cell engagers as immunotherapies for cancer, including adverse event management.

Module 6

Oncolytic Viruses and Intralesional Therapy

Updated Version Available Now (As of 11/29/2022*)

Oncolytic Viruses and Intralesional Therapy, will cover the biological foundation and clinical implementation of intratumoral therapies and oncolytic viruses.  This activity does not offer continuing education credit.

Module 7

CAR T Cell and Cellular Therapy

Updated Version Available Now (As of 04/05/2023*)

CAR T Cell and Cellular Therapy, will cover the mechanisms and clinical administration of cellular therapies for cancer, including an emphasis on adverse event management.

Module 8

Implementing Cancer Immunotherapy in Clinical Practice

Implementing Cancer Immunotherapy in Clinical Practice, will cover the practical aspects of instituting immunotherapy treatments in a clinical practice, such as education considerations, value-based care, and access to patient and provider resources.

Learner Notification

This program consists of eight modules. Continuing Education credit information for the modules can be found below, and at the module level. Please note, that each module counts for a maximum of 1.50 AMA PRA Category 1 Credits™ for physicians and 1.50 contact hours for nurses and 1.50 knowledge-based contact hours for pharmacists. 

Physicians / Nurses / Pharmacists CE Information

Jointly_Accredited_Provider.png

In support of improving patient care, this activity has been planned and implemented by Amedco LLC, Partners for Advancing Clinical Education (Partners), and SITC. Amedco LLC and Partners are jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statement: Upon successful completion of all content in this program, Amedco LLC and Partners designate this enduring material for a maximum of 8.5 AMA PRA Category 1 CreditsTM for physicians and 8.5 contact hours for nurses and 8.5 knowledge-based contact hours for pharmacists. Learners should claim only the credit commensurate with the extent of their participation in the activity.

Note to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 30 days of the activity to meet the deadline for submission to CPE Monitor.

Medical Physicist (CAMPEP) Credit Designation: This program has been approved by the Commission on Accreditation of Medical Physics Education Programs (CAMPEP) for a total of 8.5 MPCEC hours.

ABIM MOC Credit

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 8.5 Part 2 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program.





Certificate Program Task Force

Robert L. Ferris, MD, PhD

Chair
Robert L. Ferris, MD, PhD
UPMC Hillman Cancer Center

Umar Farooq, MD

Umar Farooq, MD
University of Iowa

Sandra Demaria, MD

Silvia Formenti, MD
Weill Cornell Medicine

Jennifer L. Guerriero, PhD

Sigrun Hallmeyer, MD
Advocate Medical Group

Marco Ruella, MD

Jose Lutzky, MD, FACP
University of Miami Sylvester Cancer Center